cGMP Capability The Center for Biocatalysis and Bioprocessing operates a state-of-the-art cGMP production facility capable of producing protein products for Phase 1 clinical studies, presenting a clear opportunity to engage biotech startups and small to mid-size pharma seeking compliant manufacturing and early clinical supply.

End-to-End Services With offerings spanning from process development to large-scale production and protein purification, CBB can be positioned as a one-stop partner for customers looking to shorten development timelines and reduce vendor management complexity.

Academic Ties Strong University of Iowa affiliation and NIH-funded training programs signal access to a pipeline of skilled researchers and potential collaboration opportunities, enabling joint grant opportunities, sponsored research, and early-access talent for client projects.

Modest Scale Advantage Operating with a focused team (11-50 employees) in a niche microbial manufacturing space suggests agility and personalized service ideal for startups needing flexible engagement terms, rapid iterations, and responsive technical support.

Industrial-Academic Bridge CBB’s positioning at the intersection of academia and industry, plus cGMP capabilities in Iowa, can be leveraged to target regional biotech clusters seeking proximity to university-led innovation, collaboration on translational projects, and access to funded research programs.